Cargando…
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer
PURPOSE: To compare different response criteria using computed tomography (CT) and positron emission tomography (PET) in measuring response and survival in the early phase after programmed death-1 (PD-1) blockade monotherapy in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A to...
Autores principales: | Kaira, Kyoichi, Yamaguchi, Ou, Naruse, Ichiro, Umeda, Yukihiro, Honda, Takeshi, Watanabe, Satoshi, Ichikawa, Kosuke, Yanagisawa, Shin, Kasahara, Norimitsu, Higuchi, Tetsuya, Hashimoto, Kosuke, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Imai, Hisao, Iizuka, Kunihiko, Ishizuka, Tamotsu, Minato, Koichi, Suda, Satoshi, Kagamu, Hiroshi, Mori, Keita, Seki, Nobuhiko, Kuji, Ichiei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976499/ https://www.ncbi.nlm.nih.gov/pubmed/36859341 http://dx.doi.org/10.1186/s40644-023-00538-x |
Ejemplares similares
-
Prospective assessment using (18)F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
por: Yamaguchi, Ou, et al.
Publicado: (2022) -
Tumor metabolic volume by (18)F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50%
por: Yamaguchi, Ou, et al.
Publicado: (2020) -
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer
por: Hashimoto, Kosuke, et al.
Publicado: (2020) -
Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer
por: Tsuda, Takeshi, et al.
Publicado: (2023) -
Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure
por: Kaira, Kyoichi, et al.
Publicado: (2021)